Skip to content
Royan TuCAGene
  • Home
  • About
    • Gallery
  • Services
  • ImmunoVirotherapy
  • Bioinformatics
  • R & D
  • News & Articles
  • Contact
Contact Us
  • English
    • English
    • فارسی
  • Home
  • About
    • Gallery
  • Services
  • ImmunoVirotherapy
  • Bioinformatics
  • R & D
  • News & Articles
  • Contact
Royan TuCAGeneRoyan TuCAGene
Royan TuCAGeneRoyan TuCAGene

The Association Between Higher Expression of Talin-1 and the Reduced Survival Rate in Ovarian Serous Carcinoma Patients

  • Research in the Field of Cancer
Download

Categories

  • Reproductive Health, Fertility, and Infertility
  • Research in the Field of Cancer

Have an innovative idea?

We reach out to researchers and innovators in knowledge-based companies, fostering collaboration and driving the future of science together.

Contact Us

Related Posts

Whole exome sequencing identifies MAP3K1, MSH2, and MLH1 as potential cancer-predisposing genes in familialearly-onset colorectal cancer

  • 4 October 2025

Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP)

  • 4 October 2025

Cancer/testis antigens FBXO39 and CEP55 expression correlates with survival in GBM patients

  • 4 October 2025

Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens

  • 4 October 2025

Royan TuCAGene, a knowledge-based company, is a leading organization in the fields of genetics and biotechnology, established in 2015 with the aim of developing novel therapies based on genomic knowledge.

Knowledge Hub
  • Bioinformatics Insights
  • ImmunoVirotherapy Updates
  • Educational Videos
Our Services
  • Who We Are
  • Image Gallery
  • Latest News & Research
Contact information

Email: info@royantucagene.com
Phone:
+ 98 (21) 26321459
Mobile:
+98 (903) 115-7567

© ‏2026 - All rights reserved.